Skip to content. | Skip to navigation

Personal tools

  • Le CIRI sur BlueSky
  • Le CIRI sur Linkedin
Sections
You are here: Home

Search results

71 items matching your search terms.
Filter the results.
Item type

























New items since



Sort by relevance · date (newest first) · alphabetically
"Têtes chercheuses": research in cancerology, presented by the fondation ARC
The ARC Foundation brings together 5 leading cancer researchers for a 45-minute program. It will give the floor to experienced researchers and young talents, all ready to take up, together, the challenges of curing more patients.
Located in The Center / News / 2024
VirPath team wins two awards of research and innovation
The VirPath team was awarded two times during the 2023 research and innovation awards ceremony of the Université Claude Bernard Lyon 1. We look back at these awards and on the research program of the International Associate Laboratory RESPIVIR France-Canada.
Located in The Center / News / 2024
Demain, mais en mieux !
Meet with Cyrille Mathieu at the Yggdrasil festival, to learn all about viruses!
Located in The Center / News / 2024
Voeux 2024
Le CIRI vous présente ses meilleurs voeux pour l'année 2024.
Located in The Center / News / 2024
COVID-19: Multisystem Inflammatory Syndrome in Children existed before the pandemic
During the COVID-19 pandemic, multisystemic inflammatory syndrome affected 1,100 children. Since this first description in 2020, CIRI researchers, HCL clinicians and other international collaborators have discovered that this syndrome existed before COVID-19, and that other infectious agents could lead to this severe inflammatory syndrome in children. These findings are published in the New England Journal of Medicine.
Located in Teams / Walzer T - LYACTS / Actualités
CERP/PHE3ID team awarded the Shapemed@Lyon call "Projets d'amorçage"
The PHE3ID/CERP research team has been awarded with one of the first Projets d’Amorçage supported by SHAPE-Med@Lyon
Located in CERP
Launch of the Chaire industrielle REVIDA
On october 11, the Chaire industrielle REVIDA about respiratory infectious diseases, led by the researcher Sophie Trouillet-Assant (UCBL/HCL), was officially launched by the Université Claude Bernard Lyon 1, the Hospices Civils de Lyon, and bioMérieux, with the support of the Agence nationale de la recherche. It should enable the improvement of the capacity of health systems to face the emerging of new respiratory diseases.
Located in The Center / News / 2024
New publication COVID Nature communication
New publication - VIV Team in Nature communication
Located in Teams / / Dreux M - VIV / News
HERVCOV: A european project coordinated by Branka Horvat
The protein that opens doors to the medicine of the future and treatment of COVID-19
Located in Teams / Horvat B - IbIV / Actualités
Antibiotic resistance: How some bacteria acquire resistance genes from their environment?
Antibiotic resistance has made certain infections, sometimes common, such as urinary and respiratory infections, impossible to treat, representing a major setback in the medical care of human and animal patients. This resistance has thus become a major health issue, which has led the WHO (World Health Organization) to establish a list of bacteria in which antibiotic resistance is particularly worrying.In a new study published in the journal mBio, we focused on one of these bacteria that are particularly resistant to antibiotics, Acinetobacter baumannii. The latter is responsible for many opportunistic and nosocomial infections. We have determined the mechanisms that allow this bacterium to rapidly acquire resistance genes from neighboring bacteria.
Located in Teams / Charpentier X - Horigene / News